Document is current
Any future updates will be listed below
-
Authors
Lujan, Celia
Tyler, Eleanor Jane
Ecker, Simone
Webster, Amy Philomena
Stead, Eleanor Rachel
Martinez-Miguel, Victoria Eugenia
Milligan, Deborah
Garbe, James Charles
Stampfer, Martha Ruskin
Beck, Stephan
Lowe, Robert
Bishop, Cleo Lucinda
Bjedov, Ivana http://orcid.org/0000-0001-5894-6016
-
Funding
Funding for this research was provided by:
European Research Council (ERC StG 311331, PoC 842174)
Wellcome Trust (218274/Z/19/Z)
Cancer Research UK (C416/A25145)
Cancer Research UK (C7893/A28990)
UK Research and Innovation (MR/K501372/1, BB/P002579/1, BB/N503629/1)
Office of Nuclear Energy (DE-AC02-05CH11231))
Congressionally Directed Medical Research Programs (BC141351)
- License Information
-
More Information
Article History
Received: 13 November 2023
Accepted: 21 May 2024
First Online: 2 July 2024
Declarations
:
: Normal finite lifespan human dermal fibroblasts (HDFs) were obtained from face lift dermis following a kind donation from a 42-year-old female, anonymous healthy patient, under standard ethical practice, reference LREC No. 09/HO704/69. Normal finite lifespan adult human mammary fibroblasts (HMFs) were obtained from reduction mammoplasty tissue of a 16-year-old individual, donor 48 []. The tissue was obtained in 1980 based on a pathology consent form and distributed to us under a current IRB which explicitly allows distribution of materials.
: All authors approved the final manuscript before submission.
: The authors declare no competing interests.
